Welcome to our dedicated page for CANNAGISTICS news (Ticker: CNGT), a resource for investors and traders seeking the latest updates and insights on CANNAGISTICS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CANNAGISTICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CANNAGISTICS's position in the market.
Cannagistics, Inc. (OTC PINK:CNGT) reappointed James W. Zimbler as President/CEO and Chairman to lead a rebranding initiative for its health and wellness products under the new brand, Wholistic Company. The company plans to withdraw a previously filed offering and abandon plans for a name change and reverse stock split. Zimbler expressed optimism about this transition with support from Jim Morrison and Emergent Health Corp. The company develops consumer products focusing on pain relief, pharmaceuticals, and skincare, trading under the symbol CNGT.
Cannagistics, Inc. (OTC PINK:CNGT) announced on January 3, 2022, plans to market its new product line in Q1 2022. Jim Morrison has been appointed as President/CEO and Chairman, succeeding Rob Gietl. Morrison brings significant experience from L'Oreal and Graham Webb, potentially driving growth in Cannagistics' products, including ImmuniZin, Canagel, and KidzStrips. The company is focusing on health and wellness innovations, with ongoing product development led by Dr. Ghalili and Chief Scientist John Borja.
Cannagistics, Inc. (OTC PINK:CNGT) has completed the acquisition of The Integrity Wellness Group, Inc. from Availa Bio, effective July 1, 2021. The company aims to pivot from a logistics-focused business to health and wellness products. Leadership includes Rob Gietl as President, Jim Morrison as Chairman, and Dr. Babak Ghalili as Chief Science Officer. The Integrity Wellness Group boasts a diverse product portfolio, including FDA-cleared and patented items. The company is also applying for an OTCQB listing to enhance its market presence.
Cannagistics, Inc. (CNGT) is nearing completion of its Global3pl Logistical Software SAAS Platform, with a launch planned for May 1, 2021. The platform aims to enhance operations through partnerships with various logistics providers. Additionally, the company is finalizing a transaction with Recommerce Group, Inc. which is anticipated to close around April 1, 2021. This integration is expected to streamline operations and enhance revenue through combined technologies. The development reflects Cannagistics' strategy to disrupt the logistics marketplace.
Cannagistics, Inc. (OTC PINK:CNGT) continues to develop its logistics software platforms, Global3pl and AFX, focusing on a North American supply chain initiative. The company aims to enhance efficiency in logistics, including forward and reverse supply chain management, e-commerce fulfillment, and last-mile delivery by leveraging multiple digital platforms. Plans to partner with supply chain providers are expected to materialize, with details to be shared in Q4 2020 and Q1 2021.
FAQ
What is the market cap of CANNAGISTICS (CNGT)?
